This page lists the SEC filings reported by STONEPINE CAPITAL, L.P..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2020-12-22 | STONEPINE CAPITAL, L.P. | Amryt Pharma plc | 11,050,350 | 6.2% | EDGAR |
| SC 13D/A | 2019-03-20 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 3,403,402 | 7.3% | EDGAR |
| SC 13D/A | 2016-11-21 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 2,599,711 | 24.4% | EDGAR |
| SC 13G | 2016-11-17 | STONEPINE CAPITAL, L.P. | ALIMERA SCIENCES INC | 3,529,139 | 5.4% | EDGAR |
| SC 13G | 2016-11-02 | STONEPINE CAPITAL, L.P. | TRINITY BIOTECH PLC | 1,480,000 | 6.2% | EDGAR |
| SC 13G | 2016-09-23 | STONEPINE CAPITAL, L.P. | Tobira Therapeutics, Inc. | 800,000 | 4.3% | EDGAR |
| SC 13G/A | 2016-09-16 | STONEPINE CAPITAL, L.P. | QLT INC/BC | 5,778,496 | 10.9% | EDGAR |
| SC 13G | 2016-09-16 | STONEPINE CAPITAL, L.P. | Cardiome Pharma Corp | 1,778,317 | 5.6% | EDGAR |
| SC 13G | 2016-07-21 | STONEPINE CAPITAL, L.P. | Recro Pharma, Inc. | 524,002 | 5.5% | EDGAR |
| SC 13G | 2016-07-11 | STONEPINE CAPITAL, L.P. | QLT INC/BC | 3,810,781 | 7.2% | EDGAR |
| SC 13D/A | 2016-06-21 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 2,599,711 | 25.5% | EDGAR |
| SC 13D/A | 2016-03-24 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 18,397,682 | 30.7% | EDGAR |
| SC 13G | 2016-03-24 | STONEPINE CAPITAL, L.P. | PERNIX THERAPEUTICS HOLDINGS, INC. | 3,739,079 | 6.1% | EDGAR |
| SC 13G/A | 2016-02-12 | STONEPINE CAPITAL, L.P. | Aegerion Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | STONEPINE CAPITAL, L.P. | ENZON PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | STONEPINE CAPITAL, L.P. | PAIN THERAPEUTICS INC | 3,575,000 | 7.8% | EDGAR |
| SC 13G/A | 2016-02-12 | STONEPINE CAPITAL, L.P. | PERNIX THERAPEUTICS HOLDINGS, INC. | 2,484,649 | 4.1% | EDGAR |
| SC 13G/A | 2016-02-12 | STONEPINE CAPITAL, L.P. | PHOTOMEDEX INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | STONEPINE CAPITAL, L.P. | Tobira Therapeutics, Inc. | 833,377 | 4.4% | EDGAR |
| SC 13G/A | 2016-02-12 | STONEPINE CAPITAL, L.P. | Vericel Corp | 2,376,542 | 10.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.